Gilead Banks on Remdesivir Strength to Raise 2020 Profit Forecast
U.S drugmaker Gilead raised its total product sales forecast to the range of $24.30 billion to $24.35 billion, on increased sales of remdesivir, reports Reuters. The company raised its adjusted…